As of early May 2026, the Centers for Disease Control and Prevention has confirmed 1,842 measles cases across 39 U.S. jurisdictions, with 93% linked to 25 ongoing outbreaks and 92% occurring in individuals who are unvaccinated or have unknown vaccination status. This surge, already outpacing the full-year 2025 total in several states including Utah and South Carolina, stems primarily from sustained transmission in underimmunized communities following measles introductions via international travel. Official data show low hospitalization rates so far but highlight risks of further spread during summer travel peaks. Traders are monitoring weekly CDC surveillance updates and any shifts in state-level outbreak containment, as case thresholds and elimination-status reviews could alter market resolution by year-end.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,669,907 Vol.
$7,669,907 Vol.
31 dic 2026
↑2k
99%
↑3k
62%
↑4k
28%
↑5k
14%
↑7,5k
14%
↑10k
9%
↑12,5k
5%
$7,669,907 Vol.
$7,669,907 Vol.
31 dic 2026
↑2k
$45,436 Vol.
99%
↑3k
$50,414 Vol.
62%
↑4k
$170,864 Vol.
28%
↑5k
$215,382 Vol.
14%
↑7,5k
$174,338 Vol.
14%
↑10k
$6,493,875 Vol.
9%
↑12,5k
$344,846 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the Centers for Disease Control and Prevention has confirmed 1,842 measles cases across 39 U.S. jurisdictions, with 93% linked to 25 ongoing outbreaks and 92% occurring in individuals who are unvaccinated or have unknown vaccination status. This surge, already outpacing the full-year 2025 total in several states including Utah and South Carolina, stems primarily from sustained transmission in underimmunized communities following measles introductions via international travel. Official data show low hospitalization rates so far but highlight risks of further spread during summer travel peaks. Traders are monitoring weekly CDC surveillance updates and any shifts in state-level outbreak containment, as case thresholds and elimination-status reviews could alter market resolution by year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Feb 16, 2026, 11:51 AM ET
Volume
$7,669,907Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the Centers for Disease Control and Prevention has confirmed 1,842 measles cases across 39 U.S. jurisdictions, with 93% linked to 25 ongoing outbreaks and 92% occurring in individuals who are unvaccinated or have unknown vaccination status. This surge, already outpacing the full-year 2025 total in several states including Utah and South Carolina, stems primarily from sustained transmission in underimmunized communities following measles introductions via international travel. Official data show low hospitalization rates so far but highlight risks of further spread during summer travel peaks. Traders are monitoring weekly CDC surveillance updates and any shifts in state-level outbreak containment, as case thresholds and elimination-status reviews could alter market resolution by year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,669,907Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early May 2026, the Centers for Disease Control and Prevention has confirmed 1,842 measles cases across 39 U.S. jurisdictions, with 93% linked to 25 ongoing outbreaks and 92% occurring in individuals who are unvaccinated or have unknown vaccination status. This surge, already outpacing the full-year 2025 total in several states including Utah and South Carolina, stems primarily from sustained transmission in underimmunized communities following measles introductions via international travel. Official data show low hospitalization rates so far but highlight risks of further spread during summer travel peaks. Traders are monitoring weekly CDC surveillance updates and any shifts in state-level outbreak containment, as case thresholds and elimination-status reviews could alter market resolution by year-end.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti